关键信息
-
基因名
C1QTNF3/CTRP3
- 应用
-
别名
CORS26; CTRP3; Corcs; Cors; Cartonectin; Collagenous repeat-containing sequence 26 kDa protein
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BXJ4
-
表达区间
Gln23~Lys246
-
分子量
28kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
C1QTNF3, also known as C1q/TNF-related protein 3 (CTRP3), is a member of the CTRP family that plays a crucial role in various physiological and pathological processes, including metabolism, inflammation, and cardiovascular health. The protein exhibits structural similarities to adiponectin and is involved in regulating glucose metabolism, insulin sensitivity, and lipid homeostasis, making it particularly relevant in the context of obesity and type 2 diabetes. Recent studies suggest that CTRP3 has anti-inflammatory properties and may contribute to the protection against vascular injury and metabolic syndrome. Given its potential therapeutic implications, research focusing on the recombinant production of C1QTNF3/CTRP3 seeks to explore its physiological roles further and evaluate its efficacy as a biomarker or therapeutic target for metabolic diseases. Investigating the biological functions and mechanisms of action of this protein not only enhances our understanding of metabolic regulation but also paves the way for developing innovative treatment strategies for obesity-related disorders. As the demand for effective therapies increases, the recombinant protein's characterization and analysis can facilitate further clinical applications and improve disease management outcomes for patients suffering from metabolic syndromes.
